About the study This phase IV trial was a multi-center, open-label study to evaluate the synergistic effects of Restylane Lyft or Contour in combination with Sculptra for cheek augmentation and correction of contour deficiencies, in patients experiencing facial volume loss following treatment with one of four brands of glucagon-like peptide-1 (GLP-1) receptor agonists
It may also be considered in supportive care conversations related to cataracts, glaucoma, aging, alcoholism, heart disease, liver disease, lung disease, Alzheimer's disease, Parkinson's disease, osteoarthritis, immune system concerns, and other chronic wellness concerns
3 multiple-use glass vials 30mL each
On the other hand, preclinical studies and clinical trials highlight the potent anti-inflammatory effects of TB-500 in various models of organ and tissue injury, including in the skin, eye cornea, liver, and central nervous system [34, 35, 38, 39]
After losing over 19 pounds, 14.3 inches (11.6 off waist) on GLP-1, and increasing lean mass 3% a client came to us at a crossroads
